Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immune response to hepatitis B virus.

J A Waters1, M Pignatelli, D Brown

  • 1Department of Academic Medicine, Royal Free Hospital, London, UK.

Postgraduate Medical Journal
|January 1, 1987
PubMed
Summary

Immune responses targeting hepatitis B virus (HBV) nucleocapsid and envelope proteins are crucial for clearing infected cells and preventing reinfection. Antibody responses to HBsAg, particularly the RFHBs1 epitope, are key in vaccine-induced protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority.

Gene therapy·2007
Same author

Expression and functions of human endogenous retroviruses in the placenta: an update.

Placenta·2004
Same author

Considerations in the relationship between the American College of Chest Physicians and industry.

Chest·2001
Same author

Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus.

Journal of virology·2000
Same author

The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein.

Journal of molecular biology·2000
Same author

Retroviral RNA dimer linkage.

The Journal of general virology·1999

Area of Science:

  • Immunology
  • Hepatitis B Virus Research
  • Vaccinology

Background:

  • Cell-mediated immunity targeting hepatitis B core antigen (HBcAg) and hepatitis B e antigen (HBeAg) aids in clearing HBV-infected hepatocytes.
  • Interferon and humoral responses modulate this cell-mediated process.
  • Antibodies to hepatitis B surface antigen (HBsAg) envelope proteins are vital for protective immunity, though the roles of pre-S and S determinants in neutralization are not fully understood.

Purpose of the Study:

  • To analyze the specificity of anti-HBs immune responses in individuals vaccinated against hepatitis B.
  • To compare the immune response in vaccinees to that observed during natural hepatitis B virus infection recovery.

Main Methods:

  • Analysis of antibody specificities against hepatitis B virus (HBV) determinants.

Related Experiment Videos

  • Detailed characterization of anti-HBs responses in vaccine recipients.

    • Main Results:

    • Antibodies binding to the RFHBs1 epitope (HBs sequence 124-137) confer protection against HBV infection.
    • These protective antibodies are found in individuals who recovered from natural HBV infection and in recipients of plasma-derived and recombinant hepatitis B vaccines.
    • The anti-HBs response in vaccinees mirrors the qualitative aspects of the response seen in naturally recovered individuals.

    Conclusions:

    • The immune response to hepatitis B virus (HBV) vaccination, particularly the anti-HBs response, elicits protective immunity similar to natural infection.
    • The RFHBs1 epitope is a significant target for protective antibodies, crucial for both vaccine-induced and natural immunity against HBV.
    • Understanding these immune responses can inform the development of more effective hepatitis B vaccines.